InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Yancopoulos George, Président et Directeur Scientifique. Director active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 16 reports have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €64.1m. History available since 12 January 2021. The latest transaction was filed on 31 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Yancopoulos George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
28,570 股0Common StockSEC:0001226690-26-000002:0
146,815 股@ US$555.6729.6% 占其流量Common StockSEC:0001226690-25-000005:0
75,799 股0Common StockSEC:0001883850-24-000033:0
111 股@ US$965.690.0% 占其流量Common StockSEC:0001968202-24-000093:0
907 股@ US$967.400.4% 占其流量Common StockSEC:0001968202-24-000094:0
16,848 股@ US$900.006.0% 占其流量Common StockSEC:0001883850-24-000012:0
36,296 股0Common StockSEC:0001883850-24-000013:0
172,723 股@ US$399.6628.0% 占其流量Common StockSEC:0001968202-24-000068:0
16,848 股@ US$900.006.0% 占其流量Common StockSEC:0001883850-24-000007:0
25,155 股Common StockSEC:0001883850-23-000095:0
254 股@ US$800.590.1% 占其流量Common StockSEC:0001883850-23-000062:0
13,189 股@ US$800.084.3% 占其流量Common StockSEC:0001883850-23-000044:0
239,063 股@ US$179.1317.0% 占其流量Common StockSEC:0001883850-21-000034:0
773 股@ US$625.000.2% 占其流量Common StockSEC:0001708138-21-000055:0
50,000 股@ US$600.0611.4% 占其流量Common StockSEC:0001708138-21-000044:0
82,108 股0Common StockSEC:0001708138-21-000026:0
16 条申报中的 16 条
About Yancopoulos George
YANCOPOULOS GEORGE is Président et Directeur Scientifique, with a stated role of Bd. Co-Chair, President & CSO at Regeneron Pharmaceuticals, INC. He has 16 filings in total, and across the sampled recent filings the dominant transaction nature is Cession, with 0 in buys and 64105622 in sells, over the period from 2021-06-23 to 2026-01-05.
